Judy O’Grady, a partner in Troutman Pepper Locke’s Health Care + Life Sciences Industry Group, was quoted in the September 12, 2025 Axios Pro article, “Pharma Ads Under Firm as Health Marketing Deal Pipeline Grows.”

  • “I got the question, ‘Do we pull ads? Should we pull everything?'” says Troutman Pepper Locke partner Judy O’Grady. “It depends on what your letter said.”
  • O’Grady expects legal challenges but notes a First Amendment argument likely won’t hold given the administration is proposing to lengthen, not ban, advertisements.
  • What’s next: In the meantime, while companies wait for more information, “I won’t advise my clients to add everything in the label as the administration is suggesting,” O’Grady says.
Insight Industries + Practices